Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-19
1998-05-19
Ramsuer, R. W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514885, 549405, 549406, C07D31104, A61K 3135
Patent
active
057536953
ABSTRACT:
The invention relates to a compound of formula (I) ##STR1## wherein X is a pharmacologically acceptable anion,
REFERENCES:
patent: 3266903 (1966-08-01), Jurd
patent: 3617268 (1971-11-01), Murakami et al.
patent: 4105675 (1978-08-01), Iacobucci et al.
patent: 4258055 (1981-03-01), Lietti et al.
Baranac et al., CA 112:197949 (1990), registry No. 20921-31-7.
Baranac et al., CA 112:118124 (1990), registry No. 20931-21-9 amd 83615-98-9.
Baranac et al., CA 107:115077 (1987), registry No. 1222-48-6, 4082-08-0 and 20921-31-7.
Gavrilyuk et al., CA 99:196625 (1983), registry No. 30463-83-3.
Horie et al., CA 99:131343 (1983), registry No. 30463-83-3.
O'Neill et al., CA 98:68685 (1983), registry No. 4082-08-0.
Timberlake et al., CA 87:150302 (1977), registry No. 1090-74-0 and 20931-18-4.
Nekhoroshev et al., CA 87:117749 (1977), registry No. 63960-01-0.
Busetta et al., CA 81:42658 (1974), registry No. 53062-79-6.
Timberlake et al., CA 72:43454 (1970), registry No. 20921-31-7, 20931-18-4, 20931-21-9, 26091-45-2 and 26091-50-9.
Timberlake et al., CA 70:11494 (1969), registry No. 20921-31-7, 20931-18-4, 20931-21-9.
Bendz et al., CA 67:64180 (1967), registry No. 4082-08-0.
Bendz et al., CA 67:64180 (1967), registry No. 4134-79-6.
Kokkinos et al., CA 79:114730 (1973), registry No. 6587-05-9.
Jurd, CA 66:2439 (1967), registry No. 6587-04-8.
Murakami et al., CA 71:3277 (1969), registry No. 6587-03-7.
Harper et al., CA 66:101939 (1967), registry No. 6845-96-1.
Bendz et al., CA 67:64180 (1967), registry No. 15402,17-2.
Harper et al., CA 66:101939 (1967), registry No. 15896-53-4.
Harper et al., CA 66:101939 (1967), registry No. 15896-50-1.
Jurd, CA 71:29862 (1969), registry No. 24531-81-5.
Timberlake et al., CA 68:28493 (1968), registry No. 1151-98-0.
Bate-Smith et al., CA 67:8699 (1967), registry No. 1154-78-5.
Huff, Journal of Medicinal Chemistry, Aug. 1991, vol. 34, No. 8, pp. 2305-2314.
CA120:153045 Mahmood, (Antiviral Res. (1993), 22 (2-3), 189-99;CA119:111945 Tao, (Zhongguo Yixue Kexueyuan Xuebao (1992), 14(5), 334-8);CA119:62454 Nakashima, (Antiviral Res. (1992), 18(1), 91-103); CA119:314 Kilkuskie, (Bioorg. Med. Chem. Lett. (1992), 2(12), 1529-34; CA117:245072 Moore, (Biochem. J. (1994), 2 88(3), 717-19); CA117:204523 Ono, (Eur. J. Biochem., (1991), 199(3), 769); CA114:240605 Nonaka, (PCT WO 9004968, May 17, 1990); CA113:163 Ono, (Eur. J. Biochem., 1990, 190(3), 469-76); CA110:147191 Take, (J. Antibiot. (1989), 42(1), 107-115).
Balint Janos
Borbely Ildiko
Kiss Jolan
Sulyok Gyorgy
Toth Ferenc D.
Biogal Gyogyszergyar RT
Ramsuer R. W.
Stockton Laura L.
LandOfFree
Flavilium compounds and method of using does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Flavilium compounds and method of using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flavilium compounds and method of using will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1853545